v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net (loss) income $ (1,933) $ 17,433
Reconciliations of net (loss) income to net cash used in operating activities:    
Depreciation and amortization 4,430 3,996
Non-cash operating lease expense 3,562 3,304
Net investment amortization (accretion) and losses (gains) recognized 546 137
Losses recognized on disposal of property   16
Deferred income taxes (1) 22
Share-based compensation 5,245 4,923
Changes in certain operating assets and liabilities:    
Trade accounts receivable (52,866) (29,642)
Income taxes 13,530 2,986
Prepaid expenses and other (5,931) (7,071)
Accounts payable (430) (1,854)
Accrued payroll and related benefits 34,619 24,232
Payroll taxes payable (14,001) (8,659)
Other accrued liabilities (9,513) 370
Premium payable (42,690) (41,169)
Workers' compensation claims liabilities (9,059) (14,449)
Operating lease liabilities (3,536) (3,254)
Other assets and liabilities, net 74 74
Net cash used in operating activities (77,954) (48,605)
Cash flows from investing activities:    
Purchase of property, equipment and software (11,231) (8,926)
Purchase of investments   (7,669)
Proceeds from sales and maturities of investments 21,189 13,139
Purchase of restricted investments (1,949) (35,126)
Proceeds from sales and maturities of restricted investments 14,651 64,699
Net cash provided by investing activities 22,660 26,117
Cash flows from financing activities:    
Proceeds from credit-line borrowings   4,508
Payments on credit-line borrowings   (4,508)
Repurchases of common stock (35,484) (17,290)
Common stock repurchased on vesting of restricted stock units and performance awards (1,344) (2,342)
Dividends paid (3,920) (4,107)
Proceeds from exercise of stock options and purchase of ESPP shares 561 816
Net cash used in financing activities (40,187) (22,923)
Net decrease in cash, cash equivalents and restricted cash (95,481) (45,411)
Cash, cash equivalents and restricted cash, beginning of period 126,334 82,588
Cash, cash equivalents and restricted cash, end of period $ 30,853 $ 37,177